These results indicate that the combination of TRAP, HMGB1 and NETs may serve as a potential biomarker for predicting breast cancer metastasis to the lungs, offering a new strategy for early detection and treatment of lung metastases in breast cancer patients (167). Here, HMGB1 is linked to breast cancer.